Effect of prokinetics in children with recurrent nocturnal retrosternal pain

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 7, 1998, Pages 565-568

  Hegar, Badriul ^a   De Pont, Saskia ^a   Vandemaele, Kris ^a   Vandenplas, Yvan ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Cisapride; Dyspepsia; Gastro oesophageal reflux; Manometry; pH monitoring; Prokinetic; Retrosternal pain

Indexed keywords

CISAPRIDE; PROKINETIC AGENT;

ADOLESCENT; AMBULATORY MONITORING; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIGASTRIC PAIN; ESOPHAGUS PH; ESOPHAGUS PRESSURE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; THORAX PAIN;

EID: 0031848069     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199807000-00007     Document Type: Article

References (26)

1. Vandenplas Y, Ashkenazi A, Belli D, Boige N, Bouquet J, Cadranel S, et al. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Eur J Pediatr 1993; 152:704-711.
2. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population based study, Gastroenterology 1992; 102:1259-1568
3. Malagelada JR. Functional dyspepsia. Insights on mechanisms and management strategies. Gastroenterol Clin North Am 1996; 25:103-112.
4. Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med 1988; 108:865-879
5. Kusano M, Sekiguchi T, Kawamura O, Kikuchi K, Miyazaki M, Tsunoda T, et al. Further classification of dysmotility-like dyspepsia by interdigestive gastroduodenal manometry and plasma motilin level. Am J Gastroenterol 1997; 92:481-484.
6. Cutts TF, Abel TL, Karas JG, Kuns J. Symptom improvement from prokinetic therapy corresponds on improved quality of life in patients with severe dyspepsia. Dig Dis Sci 1996; 41:1369-1376.
7. Vandenplas Y, Belli D, Boige N, Bouquet J, Cadranel S, Cezard JP, et al. A standardized protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux. (ESPGAN Society statement). J Pediatr Gastroenterol Nutr 1992; 14:467-471.
8. Vandenplas Y, de Pont S, Devreker T, Peelers S, Hauser B, Blecker U. Day-night differences of ambulatory esophageal pressure monitoring in normal sublets. Pediatr Res 1995; 38:459(A).
9. Olson AD, Fendrick AM, Deutsch D, Chernew ME, Hirth RA, Patel C, et al. Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease. Gastrointest Endosc 1996; 44:554-561.
10. Lemann M, Dederding JP, Flourié B, Franchiseur C, Rambaus JC, Jian R. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci 1991; 36:1249-1254.
11. Bodger K, Daly MJ, Heatley RV. Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners. Ailment Pharmacol Ther 1996; 10:889-895.
12. Erwin J, Britten N, Jones R. General practitioners' views on the over-the-counter availability of H2-antagonists. Br J Gen Pract 1997; 47:99-102.
13. Scott AM, Kellow JE, Shuter B, Cowan H, Corbett AM, Riley JW, et al. Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Dig Dis Sci 1993; 38:2247-2253.
14. McDougall NI, Dickey W, Johnston BT, Collins JSA, Love AH. An audit of the role of ambulatory oesophageal pH monitoring in clinical practice. Eur J Gastroenterol Hepatol 1994; 6:523-527.
15. Watson RGP, Tham TCK, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux -the "sensitive oesophagus". Gut 1997; 40:587-590.
16. Small PK, Loudon MA, Waldron DS, Campbell FC. Importance of reflux symptoms in functional dyspepsia. Gut 1995; 36:189-192.
17. Richter JE. Dyspepsia: organic causes and differential characteristic from functional dyspepsia. Scand J Gastroenterol 1991; 26 (Suppl 182):11-16.
18. Tonini M. Recent advances in the pharmacology of gastrointestinal prokinetics. Pharmacol Res 1996; 33:217-226.
19. Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47:116-152.
20. Vandenplas Y, Belli D, Benhamou P, Cadranel S, Cezard JP, Cucchaiara S, et al. A critical appraisal of current management practices for infant regurgitation - recommendations from a working party. Eur J Pediatr 1997; 156:343-357.
21. Cucchiara S, Staiano A, Boccieri A, DeStefano M, Capozzi C, Manzi G, et al. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infant with gastro-oesophageal reflux disease Gut 1990; 31:21-25.
22. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988; 94:73-78.
23. Rösch W. Cisapride in non-ulcer dyspepsia. Scand J Gastroenterol 1987; 22:161-164.
24. Liehr H, Schmidt R. A German drug-monitoring study in general practice patients receiving cisapride for functional dyspepsia. Scand J Gastroenterol 1993; 28 (Suppl 195):54-59.
25. Heyse PM, Rambaldo R, Hazelhoff B. Factors affecting short- and long-term outcome of a short therapeutic trial with cisapride in dyspeptic patients. Scand J Gastroenterol 1993; 28 (Suppl 195):15-23.
26. Abell TL, Cutts TF, Cooper T. Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life. Scand J Gastroenterol 1993; 28 (Suppl 195):60-64.